Wednesday 2/20 Insider Buying Report: QSR, AVDR (Nasdaq.com)
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy – they expect to make money. So let’s look at two noteworthy recent insider buys. At Restaurant Brands International (QSR), a filing with the SEC revealed that on Tuesday, President,Tim Hortons Alexandre Macedo purchased 45,000 shares of QSR, for a cost of $64.73 each, for a total investment of $2.91M. Macedo was up about 0.8% on the purchase at the high point of today’s trading session, with QSR trading as high as $65.26 at last check today. Restaurant Brands International is trading down about 0.3% on the day Wednesday.
Stumpf Capital Management LLC Buys Amazon.com Inc, Sells Transocean, Mattel Inc, Encana Corp (GuruFocus)
Investment company Stumpf Capital Management LLC buys Amazon.com Inc, sells Transocean, Mattel Inc, Encana Corp, The Carlyle Group LP, Under Armour Inc, Navistar International Corp, LendingClub Corp, Och-Ziff Capital Management Group LLC, Chanticleer Holdings Inc, Las Vegas Sands Corp during the 3-months ended 2018Q4, according to the most recent filings of the investment company, Stumpf Capital Management LLC. As of 2018Q4, Stumpf Capital Management LLC owns 28 stocks with a total value of $96 million. These are the details of the buys and sells.
Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $10.9 million of Shares (GuruFocus)
Chairman, President & CEO of Merck & Co Inc (NYSE:MRK) Kenneth C Frazier sold 135,613 shares of MRK on 02/19/2019 at an average price of $80.03 a share. The total sale was $10.9 million. Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $206.05 billion; its shares were traded at around $79.24 with a P/E ratio of 34.16 and P/S ratio of 5.14. The dividend yield of Merck & Co Inc stocks is 2.50%.
A Director at Graco is Exercising Options (AnalystRatings.com)
Today it was reported that a Director at Graco (GGG), Kevin J. Gilligan, exercised options to sell 21,300 GGG shares at $15.02 a share, for a total transaction value of $990K. Following Kevin J. Gilligan’s last GGG Sell transaction on February 24, 2016, the stock climbed by 21.9%. This is Gilligan’s first transaction since reporting a Sell transaction on STRA back in December 2018.
SAGE Therapeutics Inc (NASDAQ:SAGE) Insider Trading Activity – Director Sold 49,461 shares of Stock (Market Exclusive)
Insider Trading Activity For SAGE Therapeutics Inc (NASDAQ:SAGE): Steven M Paul , Director of SAGE Therapeutics Inc (NASDAQ:SAGE) reportedly Sold 49,461 shares of the company’s stock at an average price of 161.02 for a total transaction amount of $7,964,210.22.
